Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity.

Defects in death receptor-mediated apoptosis have been linked to cancer and autoimmune disease in humans. The in vivo role of caspase 8, a component of this pathway, has eluded analysis in postnatal tissues because of the lack of an appropriate animal model. Targeted disruption of caspase 8 is lethal in utero. We generated mice with a targeted caspase 8 mutation that is restricted to the T-cell lineage. Despite normal thymocyte development in the absence of caspase 8, we observed a marked decrease in the number of peripheral T-cells and impaired T-cell response ex vivo to activation stimuli. caspase 8 ablation protected thymocytes and activated T-cells from CD95 ligand but not anti-CD3-induced apoptosis, or apoptosis activated by agents that are known to act through the mitochondria. caspase 8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase 8 deletion in T-cells leads to immunodeficiency. These findings identify an essential, cell-stage-specific role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. This is consistent with the recent identification of caspase 8 mutations in human immunodeficiency.

[1]  M. Egerton,et al.  Kinetics of mature T-cell development in the thymus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Tabak,et al.  T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[4]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[5]  Pamela J. Fink,et al.  Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand , 1998, The Journal of experimental medicine.

[6]  A. Ashkenazi,et al.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily , 2002, Nature Reviews Cancer.

[7]  R. Germain.  T-cell development and the CD4–CD8 lineage decision , 2002, Nature Reviews Immunology.

[8]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[9]  C. Benoist,et al.  Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. , 1997, Immunity.

[10]  T. Tan,et al.  Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1) , 1999, Oncogene.

[11]  Rustom Antia,et al.  Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.

[12]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[13]  A. Strasser,et al.  BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes , 2002, Nature.

[14]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[15]  R. Sékaly,et al.  Early Activation of Caspases during T Lymphocyte Stimulation Results in Selective Substrate Cleavage in Nonapoptotic Cells , 1999, The Journal of experimental medicine.

[16]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[17]  Brian Seed,et al.  Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.

[18]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[19]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[20]  J. Puck,et al.  Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II , 1999, Cell.

[21]  Mason R. Mackey,et al.  Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.

[22]  H. Maeda,et al.  Polymorphism of murine Fas ligand that affects the biological activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Tschopp,et al.  Caspase Activation Is Required for T Cell Proliferation , 1999, The Journal of experimental medicine.

[24]  R. Budd.  Death receptors couple to both cell proliferation and apoptosis. , 2002, The Journal of clinical investigation.

[25]  G. Evan,et al.  p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice , 1998, Current Biology.

[26]  Michael J. Parsons,et al.  Protein Kinase B Regulates T Lymphocyte Survival, Nuclear Factor κb Activation, and Bcl-XL Levels in Vivo , 2000, The Journal of experimental medicine.

[27]  Pascal Meier,et al.  Apoptosis in development , 2000, Nature.

[28]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[29]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[30]  A. Strasser,et al.  Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. , 1995, The EMBO journal.

[31]  J. Puck,et al.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency , 2002, Nature.

[32]  S. Nagata,et al.  Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.

[33]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[34]  K. Rajewsky,et al.  How αβ T cells deal with induced TCRα ablation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Salvesen.  Caspase 8: igniting the death machine. , 1999, Structure.

[36]  W. Leonard.  Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.

[37]  R. Zinkernagel,et al.  Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes , 1998, The Journal of experimental medicine.

[38]  J. Puck,et al.  An Inherited Disorder of Lymphocyte Apoptosis: The Autoimmune Lymphoproliferative Syndrome , 1999, Annals of Internal Medicine.

[39]  A. Cheng,et al.  Caspase-dependent cleavage of the hematopoietic specific adaptor protein Gads alters signalling from the T cell receptor , 2001, Oncogene.

[40]  A. Strasser,et al.  Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells , 2001, Current Biology.

[41]  Junying Yuan,et al.  Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE , 1998, Cell.

[42]  A. Bradley,et al.  A targeted X‐linked CMV‐Cre line , 2002, Genesis.

[43]  S. Nagata,et al.  Fas ligand-induced apoptosis. , 1999, Annual review of genetics.

[44]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[45]  A. Chinnaiyan,et al.  A role for FADD in T cell activation and development. , 1998, Immunity.

[46]  J. Tschopp,et al.  TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.

[47]  Stephen C. Jameson,et al.  Maintaining the norm: T-cell homeostasis , 2002, Nature Reviews Immunology.

[48]  Keisuke Kuida,et al.  Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[49]  K Sudo,et al.  Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart , 2002, Cell Death and Differentiation.

[50]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[51]  W. Zong,et al.  Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis , 2002, Nature Immunology.

[52]  N. Kabra,et al.  T cell-specific FADD-deficient mice: FADD is required for early T cell development , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Strasser,et al.  FADD/MORT1 regulates the pre‐TCR checkpoint and can function as a tumour suppressor , 2000, The EMBO journal.

[54]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[55]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[56]  C. Thompson,et al.  Pathways of Apoptosis in Lymphocyte Development, Homeostasis, and Disease , 2002, Cell.

[57]  S. Lowe,et al.  Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. , 1998, Genes & development.

[58]  P. Marrack,et al.  Homeostasis of αβ TCR+ T cells , 2000, Nature Immunology.

[59]  R. Flavell,et al.  Caspase knockouts: matters of life and death , 1999, Cell Death and Differentiation.

[60]  T. Hofmann,et al.  Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription , 2000, Oncogene.

[61]  D. Vaux,et al.  Apoptosis genes and autoimmunity. , 2000, Current opinion in immunology.

[62]  G. Häcker,et al.  Inhibition of caspase or FADD function blocks proliferation but not MAP kinase‐activation and interleukin‐2‐production during primary stimulation of T cells , 2002 .

[63]  Kenneth G. C. Smith,et al.  A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes , 1998, The EMBO journal.

[64]  M. Moskowitz,et al.  Defects in regulation of apoptosis in caspase-2-deficient mice. , 1998, Genes & development.

[65]  X. Wang.  The expanding role of mitochondria in apoptosis. , 2001, Genes & development.

[66]  A. Hakem,et al.  The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis , 1999, The Journal of experimental medicine.

[67]  R. Budd,et al.  Activation-induced cell death. , 2001, Current opinion in immunology.

[68]  A. Khaled,et al.  Lymphocide: cytokines and the control of lymphoid homeostasis , 2002, Nature Reviews Immunology.

[69]  J. Tschopp,et al.  The Caspase 8 Inhibitor c-FLIPL Modulates T-Cell Receptor-Induced Proliferation but Not Activation-Induced Cell Death of Lymphocytes , 2002, Molecular and Cellular Biology.